John Overdeck’s Colgate-Palmolive CL Stock Holding History

John Overdeck’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,200	Closed	-$273K	–	2926
2021 Q4	$273K	Sell	3,200 -15,900	-83%	-$1.24M	﹤0.01%	3702
2021 Q3	$1.44M	Buy	+19,100	New	+$1.52M	﹤0.01%	2281
2021 Q2	–	Sell	-9,800	Closed	-$773K	–	4099
2021 Q1	$773K	Buy	9,800 +1,800	+23%	+$141K	﹤0.01%	2547
2020 Q4	$684K	Sell	8,000 -1,000	-11%	-$82.7K	﹤0.01%	2277
2020 Q3	$694K	Buy	9,000 +600	+7%	+$45.7K	﹤0.01%	2004
2020 Q2	$615K	Buy	8,400 +2,100	+33%	+$149K	﹤0.01%	1857
2020 Q1	$418K	Sell	6,300 -7,000	-53%	-$494K	﹤0.01%	2065
2019 Q4	$916K	Sell	13,300 -2,400	-15%	-$164K	﹤0.01%	2262
2019 Q3	$1.15M	Buy	15,700 +7,000	+80%	+$508K	﹤0.01%	1861
2019 Q2	$624K	Buy	+8,700	New	+$618K	﹤0.01%	2326
2019 Q1	–	Sell	-24,400	Closed	-$1.45M	–	3066
2018 Q4	$1.45M	Buy	+24,400	New	+$1.53M	0.01%	1423
2016 Q4	–	Sell	-99,600	Closed	-$7.38M	–	3133
2016 Q3	$7.38M	Buy	99,600 +82,600	+486%	+$6.11M	0.03%	690
2016 Q2	$1.24M	Buy	17,000 +8,000	+89%	+$570K	0.01%	1587
2016 Q1	$636K	Sell	9,000 -4,000	-31%	-$266K	﹤0.01%	1898
2015 Q4	$866K	Buy	+13,000	New	+$865K	﹤0.01%	1605

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

John Overdeck's CL Position: Q2 2026 in Review

John Overdeck increased its Colgate-Palmolive (CL) stake by 1,202% in Q2 2026, buying an estimated $4.94M and bringing the position to 61,200 shares worth $5.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

John Overdeck first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $210M in Q1 2023. 2,007 funds tracked by Wall St. Rank hold CL as of Q2 2026.

John Overdeck held 61,200 shares of Colgate-Palmolive worth $5.61M as of Q2 2026.
John Overdeck bought 56,500 Colgate-Palmolive shares in Q2 2026, an estimated $4.94M.
Colgate-Palmolive made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2030 holding.
John Overdeck first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
John Overdeck's Colgate-Palmolive position peaked at $210M in Q1 2023.
2,007 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.